These findings suggest that Parkin, as the downstream molecule of RhoA, could compensate for RhoA deficiency by maintaining mitochondrial homeostasis, resulting in the prevention of age-related acceleration of cardiac dysfunction and heart failure in the absence of RhoA. The gene discussed is PRKN; the disease is heart failure.